Top

Behavioral Health

Solutions for Opioid and Substance Use Disorder Treatment Organizations

Cordant Health Solutions™ offers laboratory testing, pharmacy services and adherence monitoring tools that provide actionable insights to help improve outcomes and more effectively manage substance use disorder and treatment. 

Our solutions support evidence-based treatment recommendations and transform often-fragmented treatment protocols into a more effective recovery program, which saves you and your staff time while helping to facilitate better outcomes.

Cordant is one of the only healthcare companies offering a complete solution tailored for addiction treatment providers, including substance use disorder (SUD), opioid use disorder (OUD) and methadone and suboxone maintenance. 

Expect More From Your Lab

Learn What Makes Cordant a Comprehensive Behavioral Health Solution

Supporting the Full Spectrum of Treatment and Recovery

Easy-to-Use Online Lab and State PDMP Integration

Cordant's integrated solutions provide easy prescription drug monitoring program (PDMP) access to increase visibility and insight for prompt intervention, leading to improved patient compliance and adherence to treatment programs.

Integrated Results Management Reports

Laboratory results management reports allow you to easily monitor your testing protocols, testing frequency and positivity trends to help you offer better care for your patients.

Extensive Drug Testing Menu

Testing available for more than 180 metabolites and parent drugs

Integrated Pharmacy and Adherence Monitoring

Cordant offers a stigma-free pharmacy solution, improving access to medications used to treat opioid use disorder. Cordant’s integrated program provides comprehensive patient risk monitoring, including state PDMP and drug testing results review prior to dispensing and actionable, trended patient risk reports for prescribers.

Cordant Sentry™

With Sentry, Cordant’s online integrated solution for drug testing case management, enjoy the ease of automated patient testing randomization. With real-time results and compliance alerts, treatment providers and staff can manage patients’ testing schedules, get reports on-demand, and more.

Play Video

Watch this quick 2-minute video to learn more about Sentry.

Low-level Buprenorphine Testing with Oral Fluid

100x lower cutoff buprenorphine testing reliably detects buprenorphine in oral fluid specimens, avoiding false-negative results. An ideal testing method for addiction medicine because it doesn't require a specialized collection facility, and collections are non-invasive and observed, minimizing the potential for sample adulteration.

0 %
Patients receiving buprenorphine combined with risk-based drug testing consistently test positive for the drug

Analysis of 96 integrated patients; Jan 2017 – Sept 2018

0 %
Treatment providers who believe that Cordant Sentry improved patient accountability to their drug testing program

2018 Sentry user survey

0 %
Higher medication adherence rates among patients in Cordant’s stigma-free buprenorphine pharmacy program1 compared with independent study data2

1Analysis of 496 pharmacy patients; Jan 2017 – Sept 2018
2 Analysis of 496 pharmacy patients; Jan 2017 – Sept 2018 | Hser, Y. et al. (2013), Treatment retention among patients randomized to buprenorphine/ naloxone compared in methadone in multi-site trial. Addiction; 109(1): 79-87

What Our Clients Are Saying

Play Video

Listen to one patient tell her experience on how Cordant helped her on her road to recovery.

Please complete this form to request more information about Sentry.